$MRK Gerberding: The few large #vaccines manufacturers are almost at capacity.
We need a build up.
Done best in public-private partnership. 
Must have platform approach.
Partnership model works best.
Must not remove incentives for #pharma #biotech to innovate. 

#COVID19